As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Brightsphere Investment Group, a filing with the SEC revealed that on Wednesday, John Paulson purchased 647,263 shares of BSIG, for a cost of $9.79 each, for a total investment of $6.34M. Paulson was up about 26.6% on the buy at the high point of today's trading session, with BSIG trading as high as $12.39 at last check today. Brightsphere Investment Group is trading up about 4.1% on the day Monday.
And on Friday, Director David M. Mott bought $994,165 worth of Epizyme, buying 62,019 shares at a cost of $16.03 a piece. Epizyme is trading up about 10.3% on the day Monday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.